{
    "general_params": {
        "compounds": [
            {
                "pubchem_id": 3197,
                "compound": "quinomycin",
                "mol_mass": 1100.421,
                "molecular_formula": "C51H64N12O12S2",
                "chem_struct": "CC1C(=O)N(C2CSC(C(C(=O)N(C(C(=O)OCC(C(=O)N1)NC(=O)C3=NC4=CC=CC=C4N=C3)C(C)C)C)N(C(=O)C(NC(=O)C(COC(=O)C(N(C2=O)C)C(C)C)NC(=O)C5=NC6=CC=CC=C6N=C5)C)C)SC)C",
                "chem_synonyms": [
                    "Levomycin",
                    "Echinomycin",
                    "Quinomycin A",
                    "NSC526417",
                    "512-64-1",
                    "MLS002702903",
                    "S-426-S (Lepetit)",
                    "NSC-526417",
                    "SMR001566720",
                    "NSC 526417",
                    "Echinomycin A",
                    "SK 302B",
                    "C51H64N12O12S2",
                    "BRN 0078671",
                    "GNF-PF-1958",
                    "Stereoisomer of N,N'-(2,4,12,15,17,25-hexamethyl-11,24-bis(1-methylethyl)-27-(methylthio)-3,6,10,13,16,19,23,26-octaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo(12.12.3)nonacosane-7,20-diyl)bis(2-quinoxalinecarboxamide)",
                    "Quinomycin A (7CI,",
                    "AC1L1FE5",
                    "AC1Q6NS6",
                    "cid_3197",
                    "Neuro_000224",
                    "SCHEMBL63091",
                    "CHEMBL263730",
                    "DTXSID5031266",
                    "BDBM93922",
                    "Antibiotic C638-8, crystalline",
                    "NSC13502",
                    "LS-161",
                    "NSC-13502",
                    "1403-88-9",
                    "C 6388",
                    "2-Quinoxalinecarboxmide,N'-[2,4,12,15,17,25-hexamethyl-~ 11,24-bis(1-methylethyl)-27-(methylthio)-3,6,10,13,16,19,23~ ,26-octaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo [12.12.3]nonacosane-7,20-diyl]bis-",
                    "2-Quinoxalinecarboxmide,N'-[2,4,12,15,17,25-hexamethyl-11,24-bis(1-methylethyl) -27-(methylthio)-3,6,10,13,16,19,23,26-octaoxo-9,22-dioxa -28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosan e-7,20-diyl]bis-",
                    "N-[2,4,12,15,17,25-hexamethyl-29-methylsulfanyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-7-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-20-yl]quinoxaline-2-carboxamide",
                    "WLN: T C-16-6-16-/CE& A B C- C- 2CP E& AS CX C-S DNV GMV KOV NNV PXNV TMV A&OV D&NVTJ D1",
                    ""
                ]
            }
        ],
        "loci": {
            "accession": "JN852959.1",
            "conn_comp_cluster": [
                "Unknown"
            ],
            "complete": "Unknown"
        },
        "mibig_accession": "BGC0000415",
        "minimal": true,
        "biosyn_class": [
            "NRP"
        ],
        "publications": [
            "pubmed:0"
        ]
    },
    "personal": {
        "submitter_name": "mibig.secondarymetabolites.org",
        "submitter_institution": "MIBiG",
        "submitter_email": "info@mibig.secondarymetabolites.org"
    },
    "changelogs": [
        {
            "version": "2.0",
            "comment": "Submitted"
        }
    ]
}